onc201
Showing 1 - 16 of 16
Meningioma, Refractory Meningioma, Relapsed Meningioma Trial in Omaha (ONC201)
Not yet recruiting
- Meningioma
- +2 more
- ONC201
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Aug 21, 2023
Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)
Completed
- Recurrent Neuroendocrine Tumor
- Metastatic Neuroendocrine Tumor
- ONC201
-
Cleveland, OhioCleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
Dec 1, 2022
H3 K27M, Glioma Trial in Santa Monica (ONC201, ONC201 + Placebo, Placebo)
Recruiting
- H3 K27M
- Glioma
- ONC201
- +2 more
-
Santa Monica, CaliforniaProvidence Saint John's Cancer Institute
Nov 28, 2022
Endometrial Cancer, Metastasis Trial (Atezolizumab, ONC201)
Not yet recruiting
- Endometrial Cancer
- Metastasis
- Atezolizumab
- ONC201
- (no location specified)
Sep 12, 2022
Acute Myeloid Leukemia, MDS Trial in Omaha (ONC201)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- ONC201
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Aug 4, 2022
Glioma Trial in United States (ONC201)
Active, not recruiting
- Glioma
- ONC201
-
San Francisco, California
- +8 more
Jul 14, 2022
Glioma Trial in Philadelphia (ONC201)
No longer available
- Glioma
- ONC201
-
Philadelphia, PennsylvaniaOncoceutics
Mar 10, 2022
Glioma Trial in United States (ONC201)
No longer available
- Glioma
- ONC201
-
San Francisco, California
- +9 more
May 19, 2022
Glioblastoma, Diffuse Midline Glioma, H3 K27M Glioma Trial in United States (ONC201)
Active, not recruiting
- Glioblastoma
- +5 more
- ONC201
-
Los Angeles, California
- +4 more
Apr 8, 2022
Triple Negative Breast Cancer, Endometrial Cancer, Hormone Receptor Positive, HER2 Negative Breast Cancer Trial run by the
Completed
- Triple Negative Breast Cancer
- +2 more
- ONC201
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 17, 2021
Diffuse Intrinsic Pontine Glioma, Glioma, Malignant Trial in United States (ONC201)
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Glioma, Malignant
- ONC201
-
San Francisco, California
- +7 more
Mar 1, 2022
Glioma, H3 K27M Trial in United States (ONC201)
Available
- Glioma
- H3 K27M
- ONC201
-
Phoenix, Arizona
- +21 more
Sep 23, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Villejuif (Everolimus, ONC201, Radiotherapy)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- Diffuse Midline Glioma, H3 K27M-Mutant
- Everolimus
- +2 more
-
Villejuif, Val De Marne, FranceGustave Roussy
Jul 27, 2022
Glioblastoma Trial in Minneapolis (ONC201)
Withdrawn
- Glioblastoma
- ONC201
-
Minneapolis, MinnesotaUniversity of Minnesota
Apr 28, 2021
Advanced Glioblastoma, Advanced Colorectal Cancer, Advanced Triple-negative Breast Cancer Trial in Boston (ONC201)
Withdrawn
- Advanced Glioblastoma
- +3 more
- ONC201
-
Boston, MassachusettsMassachusetts General Hospital
Apr 28, 2021
Multiple Myeloma Trial in New York (ONC201, Ixazomib, Dexamethasone)
Terminated
- Multiple Myeloma
- ONC201
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 27, 2020